These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16002735)

  • 1. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
    Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
    J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
    Yang S; Kittlesen D; Slingluff CL; Vervaert CE; Seigler HF; Darrow TL
    J Immunol; 2000 Apr; 164(8):4204-11. PubMed ID: 10754316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
    Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
    Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
    Gagnon SJ; Wang Z; Turner R; Damirjian M; Biddison WE
    J Immunol; 2003 Sep; 171(5):2233-41. PubMed ID: 12928367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
    Bae J; Tai YT; Anderson KC; Munshi NC
    Br J Haematol; 2011 Nov; 155(3):349-61. PubMed ID: 21902685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire.
    Hernández J; Lee PP; Davis MM; Sherman LA
    J Immunol; 2000 Jan; 164(2):596-602. PubMed ID: 10623800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
    Meyer zum Büschenfelde C; Nicklisch N; Rose-John S; Peschel C; Bernhard H
    J Immunol; 2000 Oct; 165(7):4133-40. PubMed ID: 11034426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
    Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
    Stanislawski T; Voss RH; Lotz C; Sadovnikova E; Willemsen RA; Kuball J; Ruppert T; Bolhuis RL; Melief CJ; Huber C; Stauss HJ; Theobald M
    Nat Immunol; 2001 Oct; 2(10):962-70. PubMed ID: 11577350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
    Jiang H; Gao W; Sze DM; Xiong H; Hou J
    Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel HLA-A(*)0201-restricted CTL epitopes from Pokemon.
    Yuan B; Zhao L; Xian R; Zhao G
    Cell Immunol; 2012; 274(1-2):54-60. PubMed ID: 22405859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
    Chen JL; Dunbar PR; Gileadi U; Jäger E; Gnjatic S; Nagata Y; Stockert E; Panicali DL; Chen YT; Knuth A; Old LJ; Cerundolo V
    J Immunol; 2000 Jul; 165(2):948-55. PubMed ID: 10878370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
    Graff-Dubois S; Faure O; Gross DA; Alves P; Scardino A; Chouaib S; Lemonnier FA; Kosmatopoulos K
    J Immunol; 2002 Jul; 169(1):575-80. PubMed ID: 12077290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones.
    Schreurs MW; Scholten KB; Kueter EW; Ruizendaal JJ; Meijer CJ; Hooijberg E
    J Immunol; 2003 Sep; 171(6):2912-21. PubMed ID: 12960314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
    Loirat D; Lemonnier FA; Michel ML
    J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.
    Bae J; Prabhala R; Voskertchian A; Brown A; Maguire C; Richardson P; Dranoff G; Anderson KC; Munshi NC
    Leukemia; 2015 Jan; 29(1):218-29. PubMed ID: 24935722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
    Nelson D; Bundell C; Robinson B
    J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.